Stryker Corporation (NYSE:SYK) Shares Bought by AQR Capital Management LLC

Paterniano Del Favero
Agosto 5, 2017

AQR Capital Management LLC raised its position in shares of Stryker Corporation (NYSE:SYK) by 7.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. Stryker makes up 1.6% of Smithbridge Asset Management Inc. Cribstone Capital Management LLC's holdings in Stryker Corporation were worth $591,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of SYK. Fundsmith LLP increased its stake in Stryker by 4.6% in the first quarter. Mosaic Family Wealth LLC now owns 1,300 shares of the medical technology company's stock valued at $171,000 after buying an additional 44 shares during the period. Bank of Montreal Can raised its position in Stryker Corporation by 0.6% in the first quarter. UBS Asset Management Americas Inc. now owns 1,026,598 shares of the medical technology company's stock worth $135,152,000 after buying an additional 97,027 shares during the last quarter. Guardian Life Insurance Co. of America increased its stake in shares of Stryker Corporation by 0.8% in the first quarter. Moreno Evelyn V now owns 71,240 shares of the medical technology company's stock valued at $9,379,000 after buying an additional 9,555 shares during the period. Chevy Chase Trust Holdings Inc. raised its position in Stryker Corporation by 2.1% in the first quarter. James Investment Research Inc. purchased a new stake in shares of Stryker Corporation during the second quarter worth approximately $155,000. Wellington Management Group LLP now owns 4,569,118 shares of the medical technology company's stock valued at $601,525,000 after buying an additional 24,139 shares during the period. Company insiders own 7.40% of the company's stock.

Shares of Stryker Co.

Stryker Corporation (NYSE:SYK) traded down 0.47% during trading on Friday, hitting $147.10. Stryker Corporation has a 1-year low of $106.48 and a 1-year high of $148.84. The firm's 50-day moving average is $140.23 and its 200 day moving average is $130.49. The stock has a market cap of $52.75 billion, a price-to-earnings ratio of 31.71 and a beta of 0.79.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, topping the Zacks' consensus estimate of $1.51 by $0.02. Stryker had a return on equity of 15.89% and a net margin of 12.98%. The company had revenue of $3.01 billion during the quarter, compared to analysts' expectations of $2.98 billion. During the same period a year ago, the company posted $1.39 earnings per share.

The business also recently announced a quarterly dividend, which will be paid on Monday, July 31st. Shareholders of record on Friday, September 29th will be given a $0.425 dividend. The ex-dividend date was Wednesday the 28th of June 2017. This represents a $1.70 annualized dividend and a dividend yield of 1.16%. Stryker's payout ratio is 37.95%.

ILLEGAL ACTIVITY NOTICE: This piece was published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another site, it was stolen and reposted in violation of U.S. & global copyright law. The original version of this story can be accessed at

Several research analysts have recently issued reports on SYK shares. Cowen and Company set a $150.00 price objective on Stryker Corporation and gave the stock an outperform rating in a report on Wednesday, April 26th. Zacks Investment Research raised Stryker Corporation from a "hold" rating to a "buy" rating and set a $163.00 target price for the company in a research report on Monday, July 17th. Deutsche Bank AG restated a "buy" rating and set a $148.00 price objective (up previously from $135.00) on shares of Stryker in a research report on Saturday, April 29th. BidaskClub lowered Stryker Corporation from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, June 13th. Stifel Nicolaus increased their price objective on shares of Stryker from $151.00 to $158.00 and gave the company a "buy" rating in a research note on Friday, July 28th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and twelve have assigned a buy rating to the stock. The stock presently has a consensus rating of "Hold" and an average price target of $144.03. Also, insider Timothy J. Scannell sold 13,322 shares of the stock in a transaction on Tuesday, May 2nd. The stock was sold at an average price of $144.56, for a total transaction of $2,790,730.80. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Stryker Corporation is a medical technology company. Finally, Mosaic Family Wealth LLC boosted its stake in Stryker Corporation by 3.5% in the first quarter. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company's segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Altre relazioni OverNewsmagazine

Discuti questo articolo